Upcoming Virtual and In-Person Educational Events for Patients and Medical Professionals ➜ VIEW NOW

A-FNG Part Two: Chronic Mold Infections and Lyme Disease

A-FNG Part Two: Chronic Mold Infections and Lyme Disease

Please understand that Dr. Anderson and Gordon Medical cannot prescribe or recommend treatment to patients they have not seen. Byron White Formulas are only available to current GMA patients by prescription.

The formulas have changed since these articles were written, and suggested dosages are now different. Contact your practitioner to adjust your treatment. This information is provided for educational purposes only, and is not intended to diagnose or treat an individual.

Wayne Anderson, ND
Wayne Anderson, N.D.
Naturopathic Doctor/Independent Practitioner
“Patient care must integrate mind and body, incorporating the strengths of alternative and conventional medicine, and tailoring a program that recognizes the uniqueness of each person.” For more than 25 years, Dr. Anderson has known that his patients are partners in the process of learning about and treating their illness, whether they choose conventional or alternative medicine or a combination of both. He listens to understand each patient’s strengths and challenges and improve his effective interaction with them. He sees every person as complex, integrated, and unique, and believes that treatment should optimize health and well-being.
Chronic Mold Infections and Lyme Disease

Patients with Chronic Lyme disease can also have chronic fungal infections. Chronicly immune suppressed Lyme disease patients have multiple opportunistic infections that can include mold and yeast infections. Knowing when to treat Borrelia, Babesia, Bartonella, Ehrlichia, Mycoplasma or chronic mold infections can be difficult.

For most of our patients Borrelia and the co-infections need to be treated first, but not always. For some patients the fungal infection is the primary pathogen. Factors that determine an individual’s dominant pathogen will be dependent on the patient’s genetic susceptibility, the extent or number of exposures, and organism pathogenicity. For other patients their chronic mold infection will be secondary to Lyme and the co-infection. When the immune system prioritizes a fungal infection as its dominant pathogen there will be a specific symptom picture.

Symptom Review for Chronic Fungal Infections
Differential Diagnosis

Signs and symptoms of mycosis can be local and/or systemic. They often simultaneously affect multiple organ systems and defy conventional diagnosis and lab tests. Treatment protocols are often ineffective.

Superficial Symptoms

Chronic sinusitis, stuffy nose, otitis media and external, sore throat, cough, asthma, shortness of breath (SOB), esophogitis, nausea, belching, abdominal bloating, gas, irritabel bowel syndrome (IBS), anal itching, vaginosis, vaginitis, cystitis, frequent and urgent urination, skin lesions, irritations and itching, opacity of the nails.

Considering Fungus the Dominant Pathogen
  • Think mold when a patient has inflammation of the mucous membranes and neurological symptoms.
  • The patient’s mucous membrane symptoms often involve the sinuses, sore throat, asthma, allergies, IBS with gas and bloating, vaginitis, urgency to urinate.
  • These areas are itchy and irritated.
  • These inflamed areas are worse in the winter or during the wet season.
  • Symptoms are worse with mold exposure.
  • When the mood is dark and depressed.
  • Can have disruptive effects on behavior, attention, and learning.
  • Pain is usually mild and bilateral.
Treatment Can Be Broken Down into Four Categories
  • Supporting the immune system.
  • Killing the dominant pathogen.
  • Detoxification of the cells through the liver, kidney, lymphatic system and bowel.
  • Functional support, rehabilitation, or rejuvenation when needed.
These treatment approaches can be applied to patients with chronic fungal infections
  • Treating the overgrowth of mold on the mucous membrane.
  • Limiting exposure to external mold.
  • Binding the mold in the gut with neurotoxin binding agents.
  • Stabilize the overactive immune response to the fungal organisms.
  • Helping the cells eliminate the lipophillic fungal toxins.
Case Studies
Patient Demographics
  • Positive IGenex Western Blot IgM and/or IgG for Borrelai burgdorferi.
  • Patients with Lab Corp CD- 57 results range from 45 to 90.
  • C4a> 3000
  • HLA-DRB typing
  • Between the ages of 25 to 45.
  • Known tick bite, in endemic area.
  • Without complicating co-morbidities.
  • No post exertional fatigue
  • No prescription medication before treatment.
  • Patients that have responded to co-infection treatment.
Patient No. 1
Past Medical History

Previously healthy 34-year-old female with progressively worsening symptoms over the last 5 years.

Chronic allergies as a child with mild episodic asthma, dysthymic depression and IBS.

Initial interview

Chief Complaint: Unstable mood (both anxious and depressed), cognitive and memory processing problems, fatigue, difficulty falling and staying asleep.

Subjective (Patient’s reports): Dizziness, SOB, occipital head pain. Easily overwhelmed, increased problems at work due to difficulty multitasking.

Review of Systems (ROS) upon questioning patient: Head pressure, night sweats, temperature intolerance, chills, minor low back pain, and mild bilateral neuropathy in hands. Intermittent diarrhea with multiple food allergies, gas and bloating. Energy 4/10. SOB, similar to air hunger.

Assessment: Probable Babesia-Like Organism with Lyme under that, and a possible mold component.

Treatment course: 10 weeks of A-BAB, progressive dosing as tolerated to 25 drops 2-x per day followed by Mepron and Zithromax for 6 weeks.

Response after 4 Months

Improved symptoms: Memory and cognitive processing, dizziness, night sweats, temperature intolerance, chills, anxiety states.

Persisting or Unresolved Symptom Picture: Mild headache, moderate depression, and abdominal gas with bloating.

Worsening Symptoms: Back, neck and shoulder pain, moderate neuropathy in hands, left worse than right, moderate to severe bilateral leg muscle aching, and significant fatigue (energy 2/10).

Second Assessment

Babesia Symptom Picture: 70% improvement in 4 months of Babesia treatment. Borrelia symptom picture more dominant. Consider Borrelia treatment.

In the last 5 months, during Babesia treatment, her Lab Corp CD-57 dropped from 68 to 31.

Second Treatment course: Rocephin IV 2 gm bid, 4 days on 3 off, with Doxycycline 100 mg, 2 tablets 2-x per day, and Actigal.


Resolved symptoms after 2 months: Back, neck, and shoulders pain.
No headache, pressure or occipital head pain.

Improved but persistent symptoms: Mild neuropathy hands improved from moderate and now equal bilateral.
Mild bilateral muscle ache.
Sleep improved but still restless.
Fatigue (energy 4/10).

Worsening symptoms: SOB, asthma-like, severe abdominal bloating and gas,
Dark mood with flat affect.
Sinus congestion and mild sore throat.

Third Assessment

Inflammation more superficial with much of the mucous membranes involved. Neurological symptoms much improved, with only remaining neuropathy in hands now bilateral. Lyme symptom picture improved with a dominant mold presentation now.

Question: Is the abdominal bloating and gas related to the mold symptom picture, or a result of the antibiotics, or both?

Third Treatment Course

Over 3 months on A-FNG

With the probable dominant mold symptom picture this patient used A-FNG. She was sensitive to small dosages starting at 4 drops 2-x/day. Over the first 6 weeks she had disruption in her mood, energy and sleep on one drop with increases every 5 to 10 days. After reaching 12 drops she was able to increase more quickly with less aggravation in her symptoms. After 3 months she was at 20 drops 2-x per day with resolved depression, SOB, neuropathy, and muscle aches. An increase of 5 drops to 25 drops 2-x per day was uneventful.

Even with improvement of Borrelia symptoms this patient used A-Lyme Complex for one month with A-FNG. This was to continue unloading the Lyme without additional adverse effect on the gut. A-L Complex was stopped after 4 weeks without relapse in improved symptoms.

Patient No. 2
Past Medical History

45-year-old male transferring into my practice on antibiotic treatment. He has been treated for Lyme with multiple antibiotics for 2 years. His current regiment for the last three months was Bicillin LA 1.2 million units’ 2-x per week with Zithromax 500 mg daily and Flagyl 250 mg 2-x per day pulsed dose. He had little change in his symptom over the last 6 months.

Initial interview

Chief Complaint: Restless, irritable, difficulty sleeping and low energy.

Subjective (Patient’s reports): Diarrhea, gas and bloating. anal itch, hemorrhoids and acid reflex. Any food induces diarrhea.
Moderate to severe depression that is worse when abdominal symptoms are aggravated.
Generalized muscle aching worse in the back, neck and shoulders.
Large muscle fasiculations, random and fleeting, worse in the torso, thighs and shoulders.
Pain in the whole hands and joints bilateral.

Review of Systems (ROS) upon questioning patient: Sinus congestion, difficulty breathing through stuffy nose.
Plugged Eustachian tubes with difficulty hearing.
Mild sore throat.
Mild head ache
Reactive to mold exposure, feels dizzy, spacey with headache within minutes of contact.

Assessment: How many of his symptoms are still related to Lyme and the co-infection vs. chronic mold infections? What parts of his symptoms are related to drug side effects, toxicity response vs. Herx response?

Treatment Course

Patient stopped all antibiotic for a trial period to evaluate response.

Patient started A-FNG and responded to 6 drops 2-x per day and increased to 15 drops 2-x per day in the first 6 weeks. On return visit his symptoms were 70% better. He continued to improve as he increased the A-FNG to 25 drops 2-x per day.

His treatment course concluded with detox, drainage,  gut rebuilding and reinocultation.

All neurological symptoms resolved within three months.

More About Mold and Mycotoxins

Copyright 2016 Wayne Anderson
All rights reserved.
For information or permission contact Wayne Anderson, N.D.

More Articles